Literature DB >> 29454178

Caffeine use disorder: An item-response theory analysis of proposed DSM-5 criteria.

Csilla Ágoston1, Róbert Urbán2, Mara J Richman2, Zsolt Demetrovics3.   

Abstract

INTRODUCTION: Caffeine is a common psychoactive substance with a documented addictive potential. Caffeine withdrawal has been included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), but caffeine use disorder (CUD) is considered to be a condition for further study. The aim of the current study is (1) to test the psychometric properties of the Caffeine Use Disorder Questionnaire (CUDQ) by using a confirmatory factor analysis and an item response theory (IRT) approach, (2) to compare IRT models with varying numbers of parameters and models with or without caffeine consumption criteria, and (3) to examine if the total daily caffeine consumption and the use of different caffeinated products can predict the magnitude of CUD symptomatology.
METHODS: A cross-sectional study was conducted on an adult sample (N = 2259). Participants answered several questions regarding their caffeine consumption habits and completed the CUDQ, which incorporates the nine proposed criteria of the DSM-5 as well as one additional item regarding the suffering caused by the symptoms.
RESULTS: Factor analyses demonstrated the unidimensionality of the CUDQ. The suffering criterion had the highest discriminative value at a higher degree of latent trait. The criterion of failure to fulfill obligations and social/interpersonal problems discriminate only at the higher value of CUD latent factor, while endorsement the consumption of more caffeine or longer than intended and craving criteria were discriminative at a lower level of CUD. Total daily caffeine intake was related to a higher level of CUD. Daily coffee, energy drink, and cola intake as dummy variables were associated with the presence of more CUD symptoms, while daily tea consumption as a dummy variable was related to less CUD symptoms. Regular smoking was associated with more CUD symptoms, which was explained by a larger caffeine consumption.
CONCLUSIONS: The IRT approach helped to determine which CUD symptoms indicate more severity and have a greater discriminative value. The level of CUD is influenced by the type and quantity of caffeine consumption.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caffeine; Caffeine use disorder; Item response theory

Mesh:

Substances:

Year:  2018        PMID: 29454178     DOI: 10.1016/j.addbeh.2018.02.012

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  4 in total

1.  Validation of the Turkish Version of the Caffeine Use Disorder Questionnaire in an Adult Population.

Authors:  Seda Kaya; Mahmut Bodur; Merve İlhan Esgin; Funda Pınar Çakıroğlu; Ayşe Özfer Özçelik
Journal:  Int J Ment Health Addict       Date:  2021-11-01       Impact factor: 3.836

2.  Self-Medication of ADHD Symptoms: Does Caffeine Have a Role?

Authors:  Csilla Ágoston; Róbert Urbán; Zsolt Horváth; Wim van den Brink; Zsolt Demetrovics
Journal:  Front Psychiatry       Date:  2022-02-03       Impact factor: 4.157

3.  Brief Version of Caffeine Expectancy Questionnaire in Brazil.

Authors:  Guilherme Falcão Mendes; Caio Eduardo Gonçalves Reis; Eduardo Yoshio Nakano; Renata Puppin Zandonadi
Journal:  Front Nutr       Date:  2021-06-30

4.  Exploring the Relationship Between Mental Well-Being, Exercise Routines, and the Intake of Image and Performance Enhancing Drugs During the Coronavirus Disease 2019 Pandemic: A Comparison Across Sport Disciplines.

Authors:  Mami Shibata; Julius Burkauskas; Artemisa R Dores; Kei Kobayashi; Sayaka Yoshimura; Pierluigi Simonato; Ilaria De Luca; Dorotea Cicconcelli; Valentina Giorgetti; Irene P Carvalho; Fernando Barbosa; Cristina Monteiro; Toshiya Murai; Maria A Gómez-Martínez; Zsolt Demetrovics; Krisztina Edina Ábel; Attila Szabo; Alejandra Rebeca Melero Ventola; Eva Maria Arroyo-Anlló; Ricardo M Santos-Labrador; Inga Griskova-Bulanova; Aiste Pranckeviciene; Giuseppe Bersani; Hironobu Fujiwara; Ornella Corazza
Journal:  Front Psychol       Date:  2021-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.